GlobeNewswire

Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
03/11/2026
MONTREAL and CHARLOTTE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
VivoSim Labs and Chemveda Life Sciences Join Forces to Put AI-Designed Drug Candidates to the Human Test
03/11/2026
Collaboration closes the loop between AI drug design and human biology: Chemveda designs and makes the molecules, VivoSim’s NAMkind™ 3D human liver and intestine models show which ones are safe to advance, in weeks [...]
FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients
03/11/2026
DENVER, Nov. 03, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure [...]
Celcuity To Participate in Upcoming Investor Conferences
03/11/2026
MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, [...]
Sofwave Medical Reports Third Quarter 2026 Financial Results and Business Highlights
03/11/2026
Third quarter revenue of $28.5M, +35% year-over-year growth; IFRS gross margin of 76.6% Third quarter usage fee revenue of $13.3M, +60% year-over-year growth First nine months revenue of $82.9M, +41% year-over-year [...]
Vivos Inc. Announces Expansion of IsoPet® Animal Cancer Division with Four New Veterinary Clinics Across the United States
03/11/2026
Kennewick, WA, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT) for the treatment of cancerous tumors, is pleased to announce [...]
OneMedNet Receives High Six-Figure Add-On Order Under Multiyear Agreement Announced September 30
03/11/2026
Expansion option exercised within weeks as customer increases data volume to support its derivative data offering MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “ [...]
KFSH Highlights AI’s Role in Patient Experience and Nursing at Economist AI in Health Summit
03/11/2026
LONDON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is participating as platinum sponsor of Economist Enterprise’s AI in Health Summit, taking place on November 4 at the [...]
Evaxion to present broad biomarker data from phase 2 trial with personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
03/11/2026
New data from the phase 2 trial with EVX-01 to be presented in both an oral and poster session COPENHAGEN, Denmark, November 3, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing [...]
Autumn Reset: PROMIXX Outlines How to Pick a Leak-Proof, Easy-Clean Protein Shaker for the Gym
03/11/2026
Searches for protein shakers climb each autumn as people look for top-rated shaker bottles. Cardiff, United Kingdom, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Two things keep a shaker from smelling: the material and how [...]
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
03/11/2026
Four presentations highlight BriaCell’s Bria-OTS+™ cellular immunotherapy platform and BriaPro’s CD80-based immunotherapy programs In vitro Bria-OTS+ studies demonstrate immune-cell activation and tumor-cell killing [...]
Primmune Therapeutics to Present PRTX007 Phase 1 Pharmacology and Phase 2 INFLECTION-003 Study Design at the SITC 41st Annual Meeting
03/11/2026
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Primmune Therapeutics , a clinical-stage biotech company harnessing the power of the innate and adaptive immune systems, today announced that two abstracts on polvitolimod [...]
Cynet Adds AI Security and Stronger Identity Protection to Unified Attack Path Management Platform
03/11/2026
New release gives security teams and MSPs visibility into shadow AI, AI agents and GenAI services, and brings identity risk and ITDR investigations into one view BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cynet, the [...]
Tiny Health To Unveil New Microbiome Intelligence Features, Microbiome Age and Gut-Body Connections, at Eudēmonia Summit
03/11/2026
The two new features provide deeper insights into the effects of the microbiome on full-body health and longevity AUSTIN, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Tiny Health , the microbiome intelligence platform [...]
BioNexus Launches BGLC 1Lab Pilot for GeneMatrix Workflows at MRNA Scientific
03/11/2026
Product mini-site presents designs for customer reporting, private AI Q&A and agentic workflows; CogniAI integration would extend document processing KUALA LUMPUR, Malaysia, Nov. 03, 2026 (GLOBE NEWSWIRE) -- [...]
Diakonos Oncology DOC1021 Clinical Data in Glioblastoma Selected for Presentation at the Society for Neuro-Oncology (SNO) Annual Meeting
03/11/2026
HOUSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Diakonos Oncology Corp. (“Diakonos”), a clinical-stage biotechnology company developing a new generation of immunotherapies for aggressive cancers, today announced that an [...]
SBC Medical to Announce 3Q 2026 Financial Results
03/11/2026
Earnings conference call to be held on November 13, 2026, at 8:30 a.m. Eastern Time IRVINE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical [...]
Imprivata Wins 2026 Top InfoSec Innovator Award for AI Security and Governance
03/11/2026
Imprivata Agentic Identity Management recognized by Cyber Defense Magazine for helping organizations securely manage and govern AI agent access WALTHAM, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Imprivata , a leading [...]
Capricor Therapeutics to Report Third Quarter 2026 Financial Results and Provide Recent Corporate Update on November 10
03/11/2026
– Company to Host Conference Call on November 10, 2026, at 4:30 p.m. ET – SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum